Protein identified as new therapeutic anti-viral target for COVID-19
Measuring gene expression changes over time may help predict T1D diabetes progression
7 June 2021Mechanisms of kidney protection by gliflozins
7 June 2021Protein identified as new therapeutic anti-viral target for COVID-19
New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP) which could be a new therapeutic anti-viral target. The research also found the presence of detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality.
